Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

fda

FDA grants Fast Track designation for Moderna’s coronavirus vaccine candidate

May 13, 2020 Research and Development COVID-19, coronavirs

The FDA has granted Fast Track designation for Moderna Inc’s mRNA vaccine candidate against the coronavirus. The regulatory body had …
News
researcherssss

AMAG Pharmaceuticals to cut 30% of staff as part of restructure

May 13, 2020 Research and Development COVID-19, coronavirus

AMAG Pharmaceuticals announced that it will cut 30% of its staff, or 140 jobs, as part of a companywide restructuring. …
News
generics

Gilead signs deal with generic drugmakers to expand global supply of remdesivir

May 13, 2020 Research and Development COVID-19, coronavirus, remdesivir

Gilead Sciences has signed an exclusive licensing agreement with five generics drug companies in India and Pakistan to supply them …
News
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

May 13, 2020 Research and Development COVID-19, coronavirus

Developments in treatments for COVID-19 continue to dominate the news as the latest in hydroxychloroquine trials shows it does not …
News
trialsssssss

Researchers in Denmark testing if senicapoc drug can reduce lung damage in COVID-19 patients

May 13, 2020 Research and Development COVID-19, Sars, coronavirus

Scientists are studying if senicapoc, a treatment for sickle cell anemia, can be repurposed to mitigate damage to a COVID-19 …
News
laree2

What can previous outbreak modeling tell us about the COVID-19 pandemic?

May 11, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Interview, coronavirus, feature, pharma

Dr LaRee Tracy, a lecturer at San Diego State University and Director of Biostatistics at PHASTAR, led a team of …
Feature
korea_govt

South Korea says Ebola drug remdesivir may not be suitable for all coronavirus patients

May 6, 2020 Research and Development COVID-19, coronavirus, south korea

South Korea says that remdesivir, traditionally used in treating Ebola, may not be effective enough in treating COVID-19 patients. South …
News
fda2outsideweb

AZ’s Farxiga becomes first FDA-approved SGLT2 inhibitor for heart failure with reduced ejection fraction

May 6, 2020 Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, heart failure

The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular …
News
partnership

Portola Pharmaceuticals to merge with Alexion in $1.41bn cash deal

May 6, 2020 Research and Development, Sales and Marketing Alexion, Portola Pharmaceuticals, pharma

Alexion has announced it is to acquire Boston-based blood disorder specialist Portola Pharmaceuticals in a transaction to the value of …
News
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

May 6, 2020 Research and Development COVID-19, coronavirus

Vaccines and treatments for COVID-19 continue to dominate the news, as two studies reveal “positive” data for Gilead’s remdesivir in …
News
trumpppppp

Ousted chief of BARDA says Trump administration ignored COVID-19 warnings

May 6, 2020 Research and Development BARDA, COVID-19, chloroquine, coronavirus, hydroxychloroquine

Ousted Director of the Biomedical Advanced Research and Development Authority (BARDA), Dr Rick Bright, alleges the Trump administration ignored warnings …
News
s300_yellow-card-govuk960

MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments

May 5, 2020 Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma

A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential …
News
shutter

Sanofi and Regeneron’s Libtayo shows durable responses in world’s most common skin cancer

May 5, 2020 Manufacturing and Production, Research and Development Cancer, Libtayo, Regeneron, Sanofi

Sanofi and Regeneron’s have lifted the lid on new topline data on their PD-1 inhibitor Libtayo (cemiplimab) in patients with …
News
kim_stratton_orphazyme

Working Life Interview: Kim Stratton, CEO, Orphazyme

May 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Orphazyme, Working Life

“Every professional faces challenges. As a woman in industry, particularly in leadership, it adds another dimension to those challenges in …
Feature
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

May 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Gilead, UK, coronaviurs

The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gilead’s …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025